Divestiture • Information Technology

ArisGlobal Acquires Boehringer Ingelheim s Benefit-Risk Analytic System

On May 11, 2022, ArisGlobal acquired information technology company Boehringer Ingelheim s Benefit-Risk Analytic System from Boehringer Ingelheim

Acquisition Context
  • This is ArisGlobal’s 1st transaction in the Information Technology sector.
  • This is ArisGlobal’s 1st transaction in Germany.

Explore All 1201 Divestiture Information Technology Deals - Search the Database Free


M&A Deal Summary

Date May 11, 2022
Target Boehringer Ingelheim s Benefit-Risk Analytic System
Sector Information Technology
Buyer(s) ArisGlobal
Sellers(s) Boehringer Ingelheim
Deal Type Divestiture

Target Company

Boehringer Ingelheim s Benefit-Risk Analytic System

Ingelheim am Rhein, Germany
Boehringer Ingelheim's Benefit-Risk Analytic System (BRASS) is a software solution designed to support causal analysis of drug safety data in a highly regulated environment.
Explore More Deals

Browse All 215,156 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyer Overview 1

Buyer

ArisGlobal

Waltham, Massachusetts, United States

Category Company
Founded 1987
Sector Internet Software and Services
Employees1,495
DESCRIPTION

ArisGlobal provides cloud-based life-sciences software that streamlines drug development, safety, regulatory, and medical affairs operations. Its AI-powered LifeSphere® platform helps pharma, biotech, and CROs automate compliance, streamline R&D operations, and accelerate the development of safer, more effective therapies. ArisGlobal was founded in 1987 and is based in Waltham, Massachusetts.


Deal Context for Buyer #
Overall 1 of 2
Sector: Information Technology 1 of 1
Type: Divestiture 1 of 1
Country: Germany 1 of 1
Year: 2022 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2023-02-28 Amplexor Life Sciences

Novo Mesto, Slovenia

Amplexor Life Sciences is a provider of regulatory, quality, and safety software solutions, serving and trusted by pharmaceutical, biotechnology, and medical device companies. Amplexor Life Sciences is based in Novo Mesto, Slovenia.

Buy -

Seller Profile 1

SELLER

Boehringer Ingelheim

Ingelheim am Rhein, Germany

Category Company
Sector Healthcare Services
DESCRIPTION

Boehringer Ingelheim is a global group of companies embracing many cultures and diverse societies.


Deal Context for Seller #
Overall 3 of 3
Sector: Information Technology 1 of 1
Type: Divestiture 3 of 3
Country: Germany 2 of 2
Year: 2022 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-09-21 Abexxa Biologics

Arlington, Texas, United States

Abexxa Biologics is a biopharmaceutical company taking an approach in the fields of immuno-oncology and oncology to develop the next generation of precision medicine. Abexxa is focused on developing novel therapeutics around its newly discovered class of intracellular antigens (atypical HLA-peptide complexes) on cancerous cells. Abexxa Biologics is based in Arlington, Texas.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-06-14 Trutino Biosciences

San Diego, California, United States

Trutino Biosciences is a research-driven biopharmaceutical company with a mission to restore immune balance in cancer patients by developing the next generation cytokine therapies that can safely activate tumor-fighting immune cells at the disease site without causing adverse side effects. Trutino Biosciences is based in San Diego, California.

Buy -